Could a ketogenic diet boost brain cancer treatment?

NCT ID NCT04730869

First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 2 times

Summary

This study tested whether adding a metabolic therapy program (fasting and a ketogenic diet) to standard treatment (chemoradiation and chemotherapy) is safe and feasible for people with glioblastoma, an aggressive brain cancer. The approach aims to starve cancer cells by lowering blood glucose and raising ketones, which normal cells can use for energy. 18 newly diagnosed patients participated, and the study measured how well they could maintain a specific blood sugar-to-ketone ratio during treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Waikato Hospital

    Hamilton, Waikato Region, 3204, New Zealand

More trials for these conditions

Other studies related to the condition(s) this trial covers.